A Matching-Adjusted Indirect Comparison of the Efficacy of Bimekizumab and Guselkumab at 52 weeks for the Treatment of Psoriatic Arthritis. (2024). SKIN The Journal of Cutaneous Medicine, 8(1), s312. https://doi.org/10.25251/skin.8.supp.312